QuickSTAT Announces Global Expansion Plan to Enhance Its Global Network and Cold Chain Logistics Capabilities for Life Sciences

14 Nov, 2014

Investment Supports Company’s Ongoing Focus on Logistics and Clinical Trial Supply Chain Integrity

New York, NY (PRWEB) November 14, 2014

QuickSTAT is making significant investments

"QuickSTAT is making significant investments to enhance our global network and Temperature-Controlled logistics capabilities to meet the evolving world of modern cold chain and the complex requirements of the Life Science industry"

As part of an ongoing global expansion plan, QuickSTAT is making significant investments in its network and logistics capabilities to meet the evolving world of modern cold chain and the complex requirements of the industry.

The expansion will support QuickSTAT’s ongoing focus on customized logistics and transportation, and includes opening new QuickSTAT Control Towers and enhancement of existing facilities. There will be an emphasis on Customer Service capabilities, to provide increased support in this increasingly complex environment. Temperature-controlled vehicles have been added to its fleet, providing additional Priority Ground Logistics Solutions.

Transportation experts specializing in Research/ Drug Development and Cold Chain Logistics from around the world have joined the QuickSTAT team, and will provide consultation on stringent regulatory compliance, specialized packaging, Dangerous Goods transport, as well as best solutions and routings, including solutions for emerging market areas.

As part of the the expansion, a Control Tower in France has been opened to support clients in the region, and a Control Tower in the UK has been expanded, both designed for GDP Quality. These QuickSTAT Control Towers will provide 24/7 transportation and logistics services, as well as in-transit storage for patient-clinical specimens, API, vaccines and investigational drugs, utilizing GDP principles and best practices. Investments in LATAM, APAC and Africa are under way.

“Our investment in an increased global footprint, the recruitment of top industry specialists, along with our market-leading IT platform that helps clients manage their clinical trials demonstrates our commitment to the Life Science community. We are very excited about the enhanced solutions and tools we can provide,” says Dominique Brown, COO, QuickSTAT.

About QuickSTAT

For 35 years, QuickSTAT has managed multinational biopharmaceutical clinical trial logistics for all phases of research and drug development, for all temperature ranges and life science products. QuickSTAT specializes in time and temperature shipping of clinical research samples, biologics, investigational drugs, clinical trial supplies, vaccines and dangerous goods, helping to bring important new drugs and medical protocols to market faster.